CIPO Announces Accelerated Examination for Patent Applications Related to the COVID-19 Response

CIPO Announces Accelerated Examination for Patent Applications Related to the COVID-19 Response

The Canadian Intellectual Property Office (CIPO) has announced the implementation of a pilot program to allow accelerated examination of patent applications at no extra charge for inventions related to medical products and processes that support the response to COVID-19. The invention must be subject to a Health Canada approval process. The pilot program is available for small entity applicants, which are universities or businesses employing 50 or fewer employees, and is limited to 50 applications.

For more information about the pilot program or other options for accelerated examination of a patent application with CIPO, please contact any of the members of our Patent Practice Group.